Vaccinations Related Content

By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.

Scientists describe COVID pneumonia as "multiple wildfires spreading across a forest" - but how different is the condition from regular pneumonia?

Potential new COVID-19 treatment may see decoy nanoparticles trick the life-threatening virus and render them inactive

A study finds that the risk of myopericarditis after COVID vaccination is low, or equivalent to the risks posed by vaccines against other diseases.

So far, there is no treatment for severe cases - but now, clinical trials for a new COVID treatment show immense promise in preventing death.

The World Health Organisation (WHO) say that the XE COVID variant (a mixture of two strains of Omicron) could be 10% more transmissible than Omicron itself.

Severe cases of inflammation from COVID-19 can occur in some people – leading to cases of acute respiratory distress and multi-organ damage.

Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines

Non-English speaking patients with COVID have a higher likelihood of needing ICU care and dying from the virus, say US scientists.

MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.

Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.

People who survive COVID-19 pneumonia, take at least one year to heal their lungs, according to a study published in Radiology.

In the context of pregnancy and COVID vaccines, a study finds that vaccination does not create complicated birth outcomes.

Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.

Here we learn from Biljana Stangeland, PhD, Executive Director, Chief Scientific Officer and Co-founder at Alv B AS, about exciting new developments in therapeutic feline and canine cancer vaccine.

Examining existing approved compounds to treat Covid-19 can significantly speed up the development of drugs.

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trials for three mRNA HIV vaccines.

Pfizer said all profits from Russia would go to "humanitarian support" for Ukraine, with future clinical trials now off the table.

Data finds that three vaccine doses can give 86% protection against the Omicron variant, reducing the chances of severe COVID-19 and death.

Separate to WHO efforts to conduct a technology transfer, Moderna signed a Memorandum of Understanding with Kenya to build the first mRNA factory in Africa.